Published in Pain on March 13, 2006
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer | NCT02549534
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy | NCT04920097
Mechanisms of acupuncture-electroacupuncture on persistent pain. Anesthesiology (2014) 2.38
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer. J Clin Oncol (2012) 1.85
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun (2006) 1.67
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol (2006) 1.59
Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocycline. Pain (2010) 1.51
Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol (2007) 1.47
Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg (2006) 1.40
Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience (2006) 1.30
Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. J Pain (2009) 1.28
Animal models of chemotherapy-evoked painful peripheral neuropathies. Neurotherapeutics (2009) 1.24
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol (2011) 1.24
Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain (2009) 1.22
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br J Pharmacol (2007) 1.21
Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J Neurosci (2012) 1.21
Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience (2011) 1.16
The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS One (2014) 1.13
Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain (2012) 1.11
Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats. J Pharmacol Exp Ther (2008) 1.10
The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience (2010) 1.10
Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat. Neuroscience (2011) 1.10
Animal models of peripheral neuropathies. Neurotherapeutics (2012) 1.09
Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy. PLoS One (2011) 1.08
Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy. J Pain (2013) 1.06
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine (2012) 1.03
Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells. PLoS One (2015) 1.02
Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Manag (2015) 1.01
New insights into mitochondrial structure during cell death. Exp Neurol (2009) 1.01
Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett (2015) 1.00
Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel. Eur J Neurosci (2011) 1.00
Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain (2009) 1.00
Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol (2014) 0.99
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN). Front Pharmacol (2013) 0.99
Role of Drp1, a key mitochondrial fission protein, in neuropathic pain. J Neurosci (2011) 0.98
Prevention of paclitaxel-induced allodynia by minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats. Mol Pain (2010) 0.97
Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecol Oncol (2015) 0.97
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. J Neurosci (2012) 0.96
Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model. PLoS One (2013) 0.94
Activating transcription factor 3 and the nervous system. Front Mol Neurosci (2012) 0.93
Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neurol (2014) 0.92
HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain. Pain (2013) 0.91
Cisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A. Am J Transl Res (2015) 0.91
Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg (2012) 0.89
Inhibition of glycogen synthase kinase 3β activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain. Neuroscience (2013) 0.89
Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy. Anesthesiology (2014) 0.89
Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research. Oncol Nurs Forum (2012) 0.88
The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. J Biol Chem (2014) 0.87
Transplant-mediated enhancement of spinal cord GABAergic inhibition reverses paclitaxel-induced mechanical and heat hypersensitivity. Pain (2015) 0.87
The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy. Brain Res (2011) 0.86
Chemotherapy-induced polyneuropathy. Part I. Pathophysiology. Contemp Oncol (Pozn) (2012) 0.85
Nociceptor-expressed ephrin-B2 regulates inflammatory and neuropathic pain. Mol Pain (2010) 0.85
Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain. J Clin Invest (2014) 0.85
Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance. Pain (2013) 0.84
Corneal innervation as a window to peripheral neuropathies. Exp Eye Res (2013) 0.84
Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies. Curr Neuropharmacol (2016) 0.83
Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ. Pain (2015) 0.83
Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). Pharmacogenomics J (2014) 0.83
Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel. Evid Based Complement Alternat Med (2013) 0.83
Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain. Neurotherapeutics (2009) 0.82
Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice. Mol Pain (2014) 0.82
Effect of ethyl pyruvate on Paclitaxel-induced neuropathic pain in rats. Korean J Pain (2013) 0.82
Altered rate-dependent depression of the spinal H-reflex as an indicator of spinal disinhibition in models of neuropathic pain. Pain (2013) 0.82
Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy. J Pain (2015) 0.82
Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy. Neuroscience (2016) 0.81
Sensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy. Neuroscience (2015) 0.81
Pain in cancer survivors. Br J Pain (2014) 0.81
Mitochondrial dependence of nerve growth factor-induced mechanical hyperalgesia. Pain (2011) 0.80
Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration. Curr Biol (2016) 0.79
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. Eur J Cancer Care (Engl) (2015) 0.78
New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy. Asia Pac J Oncol Nurs (2016) 0.78
Gender differences in paclitaxel-induced neuropathic pain behavior and analgesic response in rats. Korean J Anesthesiol (2012) 0.78
Clinical outcomes of women with metastatic breast cancer treated with nab-paclitaxel: experience from a single academic cancer centre. Curr Oncol (2013) 0.78
Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel. Neurotoxicology (2010) 0.78
An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res (2017) 0.78
Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems. Pharmacol Res (2016) 0.77
Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics. Curr Opin Support Palliat Care (2016) 0.77
Peripheral neuropathy caused by Paclitaxel and docetaxel: an evaluation and comparison of symptoms. J Adv Pract Oncol (2013) 0.77
Cooperativity between remote sites of ectopic spiking allows afterdischarge to be initiated and maintained at different locations. J Comput Neurosci (2015) 0.77
Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons. Sci Rep (2016) 0.77
Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy. PLoS One (2016) 0.77
Spinal changes of a newly isolated neuropeptide endomorphin-2 concomitant with vincristine-induced allodynia. PLoS One (2014) 0.77
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Front Mol Neurosci (2017) 0.76
Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients. Cureus (2013) 0.76
Divergent effects of painful nerve injury on mitochondrial Ca(2+) buffering in axotomized and adjacent sensory neurons. Brain Res (2014) 0.76
Chemotherapy induced peripheral neuropathic pain. Korean J Anesthesiol (2014) 0.76
Mitochondrial and bioenergetic dysfunction in trauma-induced painful peripheral neuropathy. Mol Pain (2015) 0.76
Recovery sleep does not mitigate the effects of prior sleep loss on paclitaxel-induced mechanical hypersensitivity in Sprague-Dawley rats. Biol Res Nurs (2014) 0.76
The prophylactic effects of a traditional Japanese medicine, goshajinkigan, on paclitaxel-induced peripheral neuropathy and its mechanism of action. Mol Pain (2014) 0.76
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients. Ann Clin Transl Neurol (2014) 0.76
Altered mitochondrial ATP synthase expression in the rat dorsal root ganglion after sciatic nerve injury and analgesic effects of intrathecal ATP. Cell Mol Neurobiol (2013) 0.75
A Hyperresponsive HPA Axis May Confer Resilience Against Persistent Paclitaxel-Induced Mechanical Hypersensitivity. Biol Res Nurs (2015) 0.75
Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons. Exp Neurol (2016) 0.75
EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn. Mol Pain (2016) 0.75
TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin. Aging (Albany NY) (2016) 0.75
Use of a novel high-resolution magnetic resonance neurography protocol to detect abnormal dorsal root Ganglia in Sjögren patients with neuropathic pain: case series of 10 patients and review of the literature. Medicine (Baltimore) (2014) 0.75
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc (1971) 8.56
Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci (2000) 3.73
Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol (1993) 3.18
Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell (1999) 3.14
Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res (1996) 3.00
Structure of tubulin at 6.5 A and location of the taxol-binding site. Nature (1995) 2.62
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain (2004) 2.38
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain (2004) 2.34
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain (2001) 2.28
Taxol-induced polymerization of purified tubulin. Mechanism of action. J Biol Chem (1981) 2.13
Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem (2002) 1.80
Paclitaxel-induced neuropathy. Ann Oncol (1995) 1.65
Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Lab Invest (2001) 1.50
Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Res (2000) 1.49
Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg (2006) 1.40
Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol (1995) 1.39
Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med (2001) 1.38
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst (2005) 1.37
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J Biol Chem (2001) 1.29
Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat. Ann Neurol (1998) 1.29
Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'. Cancer Res (2000) 1.27
Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol (2000) 1.23
Taxol-induced neuropathy: short-term effects of local injection. J Neurocytol (1984) 1.19
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol (1997) 1.19
Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Cancer Res (2003) 1.15
Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology (1997) 1.12
Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol (1998) 1.11
Prosaptide prevents paclitaxel neurotoxicity. Neurotoxicology (1998) 1.09
Taxol-induced neuropathy: chronic effects of local injection. J Neurocytol (1986) 1.06
Progression of paclitaxel-induced neuropathy following discontinuation of treatment. Muscle Nerve (1997) 1.05
Taxol-induced neuropathy: further ultrastructural studies of nerve fibre changes in situ. J Neurocytol (1985) 1.00
Effects of thallium salts on neuronal mitochondria in organotypic cord-ganglia-muscle combination cultures. J Cell Biol (1973) 0.95
Stimulation-associated changes in frog neuromuscular junctions. A quantitative ultrastructural comparison of rapid-frozen and chemically fixed nerve terminals. Neuroscience (1986) 0.95
Microtubule-active drugs suppress the closure of the permeability transition pore in tumour mitochondria. FEBS Lett (1996) 0.94
Paclitaxel (Taxol) induces cumulative mild neurotoxicity. Eur J Cancer (1994) 0.93
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ (2010) 3.46
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain (2004) 2.34
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87
The role of sodium channels in chronic inflammatory and neuropathic pain. J Pain (2006) 1.59
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol (2006) 1.59
Abnormal contralateral pain responses from an intradermal injection of phenylephrine in a subset of patients with complex regional pain syndrome (CRPS). Pain (2004) 1.55
Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain (2015) 1.55
Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol (2007) 1.47
Dietary fat and protein interact in suppressing neuropathic pain-related disorders following a partial sciatic ligation injury in rats. Pain (2004) 1.43
Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg (2006) 1.40
Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett (2006) 1.33
Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury. J Comp Neurol (2006) 1.25
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol (2011) 1.24
Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice. Mol Pain (2010) 1.18
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain (2012) 1.11
Norepinephrine-induced nociception and vasoconstrictor hypersensitivity in rats with chronic post-ischemia pain. Pain (2008) 1.07
Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Transl Med (2011) 1.05
Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc (2006) 1.03
A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology. Pain Med (2010) 1.02
Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies. Pain Med (2008) 1.01
Persistent low-frequency spontaneous discharge in A-fiber and C-fiber primary afferent neurons during an inflammatory pain condition. Anesthesiology (2007) 0.98
Cutaneous tactile allodynia associated with microvascular dysfunction in muscle. Mol Pain (2008) 0.93
Imaging studies in Freund's complete adjuvant model of regional polyarthritis, a model suitable for the study of pain mechanisms, in the rat. Arthritis Rheum (2011) 0.88
CNS mastitis: nothing to worry about? Vet Microbiol (2008) 0.85
Characterization of a model of cutaneous inflammatory pain produced by an ultraviolet irradiation-evoked sterile injury in the rat. J Neurosci Methods (2005) 0.84
A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain. J Pain (2002) 0.83
Neuropathic pain: a crisis of definition? Anesth Analg (2003) 0.83
Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFalpha)-positive mast cells in rats with a painful peripheral neuropathy. J Pharmacol Sci (2008) 0.82
Unpleasant odors increase pain processing in a patient with neuropathic pain: psychophysical and fMRI investigation. Pain (2005) 0.80
Novel therapies for the control and prevention of neuropathic pain. Neurotherapeutics (2009) 0.78
Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain. J Pain (2013) 0.77
Peripheral neuropathy in a woman with breast cancer. J Pain (2006) 0.77
Objectifying CRPS-I. Pain (2008) 0.76
Response to "A new definition of neuropathic pain". Pain (2012) 0.75
Questions concerning the incidence and prevalence of complex regional pain syndrome type I (RSD). Pain (2003) 0.75
Dissociation between cutaneous and deep sensibility in central post-stroke pain (CPSP). Pain (2002) 0.75